Brief: Spectracure Reports Positive Results From Co's Clinical Phase 1 Study

SpectraCure AB (publ)

02/07/2019 14:14

July 2 (Reuters) - SpectraCure AB (publ)  SPEC.ST :
    * REPORTS POSITIVE RESULTS FROM CO'S CLINICAL PHASE 1 STUDY
    * STUDY'S PRIMARY ENDPOINT REGARDING SAFETY WAS ACHIEVED

Source text for Eikon:  ID:nWkr57GPbx 
Further company coverage:  SPEC.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))